
The Controversial Rise of David Protein: $2 Billion in 2 Years
Capitalism.com with Ryan Daniel Moran
David Protein achieved a multi-billion dollar valuation within two years by leveraging a repeatable, high-growth business model. Founder Peter Rahal, previously of RXBAR, targeted an underserved demographic—women—while utilizing premium, tech-focused packaging to justify a 50% price premium. The company’s success relies on "stacking the deck" by securing influential investors and building a pre-launch waiting list to guarantee initial demand. A critical strategic advantage involved acquiring Epogee, the manufacturer of the novel, low-calorie fat ingredient EPG, effectively creating a supply-side monopoly. This move allowed the parent company, Medici, to expand into ice cream and candy, directly competing with established giants. By controlling both the product innovation and the underlying manufacturing technology, the brand transformed from a single protein bar into a scalable, multi-category conglomerate.
Sign in to continue reading, translating and more.
Open full episode in Podwise